| __timestamp | Alnylam Pharmaceuticals, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 44526000 | 31073000 |
| Thursday, January 1, 2015 | 60610000 | 43216000 |
| Friday, January 1, 2016 | 89354000 | 50679000 |
| Sunday, January 1, 2017 | 199365000 | 79171000 |
| Monday, January 1, 2018 | 382359000 | 168218000 |
| Tuesday, January 1, 2019 | 479005000 | 210796000 |
| Wednesday, January 1, 2020 | 588420000 | 203613000 |
| Friday, January 1, 2021 | 620639000 | 234273000 |
| Saturday, January 1, 2022 | 770658000 | 265784000 |
| Sunday, January 1, 2023 | 795646000 | 344501000 |
| Monday, January 1, 2024 | 975526000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Alnylam Pharmaceuticals, Inc. and Insmed Incorporated, two prominent players, have shown distinct strategies over the past decade. From 2014 to 2023, Alnylam's SG&A expenses surged by over 1,600%, reflecting its aggressive expansion and investment in administrative capabilities. In contrast, Insmed's expenses grew by approximately 1,000%, indicating a more measured approach.
Alnylam's peak in 2023, with expenses nearing $796 million, underscores its commitment to scaling operations. Meanwhile, Insmed's $345 million in the same year highlights its focus on sustainable growth. This divergence in strategy offers a fascinating insight into how biotech firms balance growth with cost management. As the industry evolves, these companies' approaches to SG&A optimization will be pivotal in shaping their competitive edge.
Sanofi or Alnylam Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Gilead Sciences, Inc. vs Alnylam Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Incyte Corporation
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Insmed Incorporated
Who Optimizes SG&A Costs Better? Insmed Incorporated or Catalent, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Dr. Reddy's Laboratories Limited
Selling, General, and Administrative Costs: Insmed Incorporated vs CymaBay Therapeutics, Inc.
Comparing SG&A Expenses: Insmed Incorporated vs HUTCHMED (China) Limited Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Evotec SE